Infinity Bio announced it raised $2.5 Million in an initial filing from an offering of $4 Million
06/26/23, 4:18 PM
Location
Money raised
$2.5 million
Industry
biotechnology
Round Type
seed
Company Info
Location
6200 seaforth st.
baltimore, maryland, united states
Additional Info
Infinity Bio is a Circulating Antibody Repertoire Profiling service company, leveraging a novel technology, MIPSA (Molecular Indexing of Proteins (or Peptides) by Self Assembly) developed by Dr. H. Ben Larman, a pioneer in this field. Our various antigen libraries provide cost effective, comprehensive and quantitative analyses of antibody responses to infections, vaccinations, self-antigens and allergens.